Current Requirements for Assessment of Elemental Impurities (Heavy Metals) in Medicines


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

One element of ensuring the quality and safety of medicines consists of normalizing and controlling elemental impurities (heavy metals). The sources and causes of the presence of elemental impurities (heavy metals) in medicines are discussed. Changes in approaches to assessment of elemental impurities in medicines in the State Pharmacopeia and leading non-Russian pharmacopeias are discussed. A risk-oriented approach to assessing elemental impurities used in international practice is presented.

Sobre autores

E. Kovaleva

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. Belanova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. Panova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. Zakharchenko

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018